Literature DB >> 13126413

The production of incomplete virus particles among influenza strains: experiments in eggs.

S FAZEKAS DE ST. GROTH, D M GRAHAM.   

Abstract

Keywords:  INFLUENZA VIRUSES

Mesh：

Year:  1954        PMID： 13126413      PMCID： PMC2073598     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  8 in total

1.  Absence of incomplete virus production in certain influenza strains.

Authors:  S FAZEKAS DE ST GROTH; D M GRAHAM
Journal:  Nature       Date:  1953-12-26       Impact factor: 49.962

2.  Multiplication of influenza virus under conditions of interference.

Authors:  S FAZEKAS DE ST GROTH; A ISAACS; M EDNEY
Journal:  Nature       Date:  1952-10-04       Impact factor: 49.962

3.  The Serial Passage of Mixtures of Different Strains of Influenza Virus in Embryonated Eggs and in Mice.

Authors:  J Y Sugg; T P Magill
Journal:  J Bacteriol       Date:  1948-08       Impact factor: 3.490

4.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.

Authors:  T Francis
Journal:  Science       Date:  1934-11-16       Impact factor: 47.728

5.  Further studies on serial passage of a mixture of influenza viruses in embryonated eggs.

Authors:  J Y SUGG
Journal:  Proc Soc Exp Biol Med       Date:  1951-01

6.  Propagation of the PR8 strain of influenza A virus in chick embryos. II. The formation of incomplete virus following inoculation of large doses of seed virus.

Authors:  P von MAGNUS
Journal:  Acta Pathol Microbiol Scand       Date:  1951

7.  Quantitative aspects of influenza virus multiplication.

Authors:  H J F CAIRNS; M EDNEY; S FAZEKAS DE ST GROTH
Journal:  J Immunol       Date:  1952-08       Impact factor: 5.422

8.  Studies on host-virus interactions in the chick embryo-influenza virus system. V. Simultaneous serial passage of the agents of influenza A and B in relation to variations in the growth cycle of influenza B virus.

Authors:  O C LIU; W HENLE
Journal:  J Exp Med       Date:  1951-10       Impact factor: 14.307
  8 in total
  12 in total

1.  The human pathogenicity of the Newcastle disease virus and its relation to the mumps, fowl plague and influenza viruses.

Authors:  J SINKOVICS
Journal:  Arch Gesamte Virusforsch       Date:  1957

2.  VIRAL INTERFERENCE. SOME CONSIDERATIONS OF BASIC MECHANISMS AND THEIR POTENTIAL RELATIONSHIP TO HOST RESISTANCE.

Authors:  R R Wagner
Journal:  Bacteriol Rev       Date:  1960-03

Review 3.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Nucleo-cytoplasmic studies in the development of influenza virus in mammaliam cells.

Authors:  W C Bell; H F Maassab
Journal:  Arch Gesamte Virusforsch       Date:  1969

5.  Serology and energetics of cross-reactions among the H3 antigens of influenza viruses.

Authors:  P A Underwood
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

6.  Synthesis of M protein of influenza B virus is specifically inhibited at a non-permissive temperature.

Authors:  K Tobita; T Tanaka; H Goto; S Feng
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Genetic recombination for antigenic markers of antigenically different strains of influenza B virus.

Authors:  K Tobita; E D Kilbourne
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

8.  The in ovo production of incomplete virus by B-Lee and A-PR8 influenza viruses.

Authors:  P von Magnus
Journal:  Arch Gesamte Virusforsch       Date:  1965

Review 9.  Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases.

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  Viruses       Date:  2015-07-08       Impact factor: 5.048

10.  Distinct susceptibility and applicability of MDCK derivatives for influenza virus research.

Authors:  Shih-Chao Lin; Matthew A Kappes; Mei-Chun Chen; Chi-Chen Lin; Tony T Wang
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.